CBD Global Sciences - Brad Wyatt, President and CEO
Brad Wyatt, President and CEO
Source: YouTube
  • CBD Global Sciences Inc. (CBDN) has acquired 100 per cent of the Colorado based company, Resinosa LLC
  • The acquisition consists of an initial issuance of 5,378,657 class A common shares and 99,889 series A preferred shares of CBD Global
  • 4,280,972 common shares will be escrowed and released in equal monthly amounts over a two-year period
  • The vendors were also issued a two-year convertible note in the principal amount of US$1.5 million with interest of 8 per cent per year
  • With its current assets Resinosa can bring in an estimated retail value $46.2 million of finished products per month
  • CBD Global Sciences Inc. (CBDN) is down 3.33 per cent and is trading at $0.29 per share at 1:46 p.m. ET

CBD Global Sciences Inc. (CBDN) has acquired 100 per cent of the Colorado-based company, Resinosa LLC.

Resinosa is a CBD processing and manufacturing company that has been in the industry for over six years.

The acquisition consists of an initial issuance of 5,378,657 class A common shares and 99,889 series A preferred shares of CBD Global.

4,280,972 common shares will be escrowed and released in equal monthly amounts over a two-year period.

CBD Global will also issue to the sellers up to an extra 4,388,906 units before April 30, 2023, if greater than US$500,000 of net income is achieved from Resinosa assets and business in fiscal 2022. The issuance will be reduced to 2,194,453 units if the net income is between $250,000 and $500,00 for the same period.

CBD Global will issue the same number of units before April 30, 2024, if more than US$1 million in net income is achieved in fiscal 2023. It will be reduced to the same amount of units if the net income is between $500,000 and $1 million.

The vendors were also issued a two-year convertible note in the principal amount of US$1.5 million with interest of 8 per cent per year.

The note is convertible to units of CBD Global, which will consist of 0.35 common shares and 0.0065 preferred shares at a price of US$0.26 per unit.

Brad Wyatt, CEO of Global Sciences, commented on what the partnership means to both companies.

“This is a huge step forward for both our companies and we have a road map developed with a pathway to increased revenues and profitability with this acquisition,” he said.

“I am delighted to have the Resinosa team join us on this project…For Resinosa’s loyal customer base it will be business as usual with a continued supply of quality production with no change in pricing.”

With its current assets, Resinosa can run extraction and processing operations on hemp biomass to produce 1,320 kilos of full-spectrum CBD oil per month.

That amount can be formulated to an estimated retail value of $46.2 million of finished products per month.

The board of CBD Global has approved Jeff Hays, CEO and founder of Resinosa, to the board of directors.

CBD Global Sciences Inc. (CBDN) is down 3.33 per cent and is trading at $0.29 per share at 1:46 p.m. ET.

More From The Market Online

Unsung profits: Three microcap stocks with a strong case for value

A key factor behind picking winning microcap value stocks is identifying dislocations between company performance and market perception.

Buzz on the Bullboards: A recap of recent activity and stocks in focus

Following a major sell-off, stock markets have been on edge, monitoring corporate earnings to gauge the direction of the economy.

The Market Online’s Weekly Cannabis Report – April 19, 2024

Cannabis news this week: Canopy Growth shareholders overwhelmingly voted to approve a new class of exchangeable shares.

Buzz on the Bullboards: Challenges amid inflation and geopolitical tensions

Canadian and U.S. stock markets grapple with a host of challenges, from surging inflation data to escalating tensions in the Middle East.